- Home/
- Research Areas/
- Neuroscience
Neuroscience

| 3 min read
Seven years ago, Genentech shares were trading for roughly $22 per share and Roche had been the majority owner of the company for a bit more than 10 years. In 2001, with agreements in place that would provide Roche with first choice to pick Genentech’s ripest fruit, I’m sure 2015 seemed forever in the future. But not anymore.

| 1 min read
Linguamatics Ltd., a provider of enterprise text mining for life science researchers, announced in June that it has joined the Microsoft BioIT Alliance, an association of life science organizations and informatics companies whose focus is to enhance collaboration and accelerate the pace of drug discovery and development.







